Abstract
Few reports have described the prognostic value of measuring both B-type natriuretic peptides (BNP) and high-sensitivity troponin T (hs-TnT) in pediatric patients with complex congenital heart disease (CHD) undergoing surgery. We assessed demographic, hemodynamic, and laboratory data, including BNP and hs-TnT levels, for the prediction of cardiac adverse events in 85 patients. Cardiac adverse events were defined as death, cardiac arrest, worsening heart failure requiring inotropic agents and/or respiratory support, and unscheduled surgery/intervention either within or after 12 months of surgery. There were 17 cardiac adverse events. Of the demographic variables, low birth weight (< 2500 g: Odds ratio [OR], 5.97; 95% confidential interval [CI] 1.48–24.0; p = 0.001) and Ross/New York Heart Association [NYHA] class (≥ 2.0) (OR 12.7; 95% CI 3.08–52.7; p = 0.0004) were strongly association with cardiac adverse events. Among hemodynamic and laboratory variables, preoperative BNP (OR 14.04; 95% CI 2.15–91.7; p = 0.001) and hs-TnT levels (OR 16.66; 95% CI 2.27–122; p = 0.002) were found to be independent risk factors. Receiver operating characteristic analysis determined BNP and hs-TnT levels of 60.9 pg/mL and 0.025 ng/mL, respectively, to be markers of high risk. Kaplan–Meier analysis demonstrated significant differences in the freedom from cardiac adverse events between Group A (BNP or hs-TnT elevated, n = 26) and Group B (both biomarkers elevated, n = 19; log-rank, p < 0.001). In conclusion, low birth weight (< 2500 g) and Ross/NYHA class ≥ 2.0 are strongly associated with cardiac adverse events. Preoperative BNP and hs-TnT also provide prognostic information in patients with complex CHD scheduled for surgery. Using both markers in combination predicts cardiac adverse events better than using either separately.
Similar content being viewed by others
References
Jenkins KJ, Gauvreau K, Newburger JW, Sprey TL, Moller JH, Iezzoni LL (2002) Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 123:110–118. https://doi.org/10.1067/mtc.2002.119064
Chang RKR, Chen AY, Klitzner TS (2002) Female sex as a risk factor for in-hospital mortality among children undergoing cardiac surgery. Circulation 106:1514–1522. https://doi.org/10.1161/01.cir.0000029104.94858.6f
Kang N, Cole N, Tsang V, Elliot M, de Leval M (2004) Risk stratification in pediatric open-heart surgery. Eur J Cardio-thorac Surg 26:3–11. https://doi.org/10.1016/j.ejcts.2004.03.038
Chang RKR, Rodriquez S, Lee M, Kitzner TS (2006) Risk factors for death occurring within 30 days and 1 year after hospital discharge for cardiac surgery among pediatric patients. Am Heart J 152:386–393. https://doi.org/10.1016/j.ahj.2005.12.016
Kogon B, Jain A, Oster M, Woodal K, Kanter K, Kirshborn P (2012) Risk factors associated with readmission after pediatric cardiothoracic surgery. Ann Thorac Surg 94:865–873. https://doi.org/10.1016/j.athoracsur.2012.04.025
Tregay J, Wray J, Bull C, Franklin RC, Daubeney P, Barron DJ, Brown K, Knowles RL (2015) Unexpected death and unplanned re-admission in infants discharged home after cardiac surgery: a systematic review of potential risk factors. Cardiol Young 25:839–852. https://doi.org/10.1017/S1047951114002492
Lurati Buse GA, Koller MT, Burkhart C, Seeberger MD, Filipovic M (2011) The predictive value of preoperative natriuretic peptide concentration in adults undergoing surgery: a systematic review and meta-analysis. Anesth Analog 112:1019–1033. https://doi.org/10.1213/ANE.0b013e31820f286f
Lurati Buse GA, Bolliger D, Seeberger E, Kapsper J, Grapow M, Koller MT, Seeberger MD, Filipovic M (2014) Troponin T and B-type natriuretic peptide after on-pump cardiac surgery: prognostic impact on 12-month mortality and major cardiac events after adjustment for postoperative complications. Circulation 130:948–957. https://doi.org/10.1161/CIRCULATIONAHA.113.007253
Braunwald E (2008) Biomarkers in heart failure. N Engl J Med 358:2148–2159. https://doi.org/10.1056/NEJMra0800239
Shih CY, Sapru A, Oishi P, Azakie A, Karl TR, Hamon C, Asija R, Adatia I, Fineman JR (2006) Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker. J Thorac Cardiovasc Surg 131:632–638. https://doi.org/10.1016/j.jtcvs.2005.10.052
Immer FF, Stocker F, Seiler AM, Pfammatter JP, Bachmann D, Printzen G, Carrel T (1999) Troponin I for prediction of early postoperative course after pediatric surgery. J Am Coll Cardiol 33:1719–1723. https://doi.org/10.1016/s0735-1097(99)00061-3
Carmona F, Manso PH, Vicente WVA, Carstro M, Carlotti APCP (2008) Risk stratification in neonate and infants submitted to cardiac surgery with cardiopulmonary bypass: a multimarker approach combining inflammatory mediators, N-terminal pro-B-type natriuretic peptide and troponin I. Cytokine 42:317–324. https://doi.org/10.1016/j.cyto.2008.03.005
Bojan M, Peperstraete H, Lilot M, Vicca S, Pouard P, Vouhe P (2012) Early elevation of cardiac troponin I is predictive of short-term outcome in neonates and infants with coronary anomalies or reduced ventricular mass undergoing cardiac surgery. J Thorac Cardiovasc Surg 144:1436–1444. https://doi.org/10.1016/j.jtcvs.2012.05.034
Walsh R, Boyer C, LaCorte J, Parnell V, Sison C, Chowdhury D, Ojamaa K (2008) N-terminal B-type natriuretic peptide levels in pediatric patients with congenital heart failure undergoing cardiac surgery. J Thorac Cardiovasc Surg 135:98–105. https://doi.org/10.1016/j.jtcvs.2007.08.012
Cantinotti M, Giordano R, Scalese M, Molinaro S, Della Pina F, Storti S, Arceri L, Murzi L, Marotta M, Park V, Poli V, Iervasi G, Clerico A (2015) Prognostic role of BNP in children undergoing surgery for congenital heart disease: analysis of prediction models incorporating standard risk factors. Clin Chem Lab Med 53:1839–1846. https://doi.org/10.1515/cclm-2014-1084
Perez-Piaya MR, Abarca E, Soler V, Coca A, Crutz M, Villagara F, Giannivelli S, Ascensio A (2011) Levels of N-terminal pro-natriuretic peptide in congenital heart disease surgery and its value as a predictive biomarker. Int Cardiovasc Thoracic Surg 12:461–466. https://doi.org/10.1510/icvts.2010.245803
Qu J, Liang H, Zhou N, Li L, Wang Y, Li J, Cui Y (2017) Perioperative NT-pro BNP level: potential prognostic markers in children undergoing congenital surgery. J Thorac Cardiovasc Surg 154:631–640. https://doi.org/10.1016/j.jtcvs.2016.12.056
Kanazawa T, Egi M, Toda Y, Shimizu K, Sugimoto K, Iwasaki T, Morimatsu H (2017) Perioperative brain natriuretic peptide in pediatric cardiac surgery patients: its association with postoperative outcome. J Cardiothorac Vasc Anesth 31:537–542. https://doi.org/10.1053/j.jvca.2016.09.008
Baggen VJM, van den Bosch AE, Eindhoven JA, Schut ARW, Cuypers JAAE, Witsenburg M, van Schaik MWRHN, Boersma EB, Roos-Hesselink JW (2017) Prognostic value of N-terminal pro-B-type natriuretic peptide, troponin T, and growth-differentiation factor 15 on adult congenital heart disease. Circulation 135:264–279. https://doi.org/10.1161/CIRCULATIONAHA.116.023255
Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, Del Nido P, Fasules JW, Graham TP Jr, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD (2008) ACC/AHA 2008 guideline for the management of adults with congenital heart disease: Executive summary. Circulation 118:2395–2451. https://doi.org/10.1161/CIRCULATIONAHA.108.190811
Ohuchi H, Takasugi H, Ohashi H, Yamada O, Watanabe K, Yagihara T, Echigo S (2004) Abnormalies of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in fontan patients. Circulation 110:2601–2608. https://doi.org/10.1161/01.CIR.0000145545.83564.51
Shah A, Feraco AM, Harmon C, Tacy T, Fineman JR, Baerson HS (2009) Useful of various plasma biomarkers for diagnosis of heart failure in children with single ventricle physiology. Am J Cardiol 104:1280–1284. https://doi.org/10.1016/j.amjcard.2006.02.058
Nagy ZL, Collins M, Sharpe T, Mirsadraee S, Guerrero RR, Gibbs J, Watterson KG (2003) Effect of two different bypass technique on serum troponin-T levels in newborn and children. Circulation 108:577–582. https://doi.org/10.1161/01.CIR.0000081779.88132.74
Law YM, Hoyer AW, Reller MD, Silberbach M (2009) Accuracy of plasma B-type natriuretic peptide to diagnosis significant cardiovascular diseases in children: the Better Not Pout Children! study. J Am Coll Cardiol 54:467–475. https://doi.org/10.1016/j.jacc.2009.06.020
Nakazawa M, Marks RA, Isabel-Jones J, Jarmakani JM (1976) Right and left volume characteristics in children with pulmonary stenosis and intact ventricular septum. Circulation 53:884–890. https://doi.org/10.1161/01.cir.53.5.884
Ross RD, Bollinger RO, Pinsky WW (1992) Grading the severity of congestive heart failure in infants. Pediatr Cardiol 13:72–75. https://doi.org/10.1007/BF00798207
Harris BU, Char DS, Feinstein JA, Verma A, Shiboski SC, Ramamoorthy C (2016) Accuracy of pulse oximeters intended for hypoxic pediatric patients. Pediatr Crit Care Med 17:315–320. https://doi.org/10.1097/PCC.0000000000000660
Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 48:452–458. https://doi.org/10.1038/bmt.2012.244
Ades AM, Dominguez TE, Nicolson SC, Gaynor JW, Spray TL, Wernovsky G, Tabbutt S (2010) Morbidity and mortality after surgery for congenital cardiac disease in the infants born with low weight. Cardiol Young 20:8–17. https://doi.org/10.1017/S1047951109991909
Alsoufi B, Manlhiot C, Mahle WT, Deshpande S, Kogon B, McCrindle BW, Kanter K (2014) Low-weight infants are at increased risk mortality after palliative or corrective surgery. J Thorac Cardiovasc Surg 148:2508–2514. https://doi.org/10.1016/j.jtcvs.2014.07.047
Best KE, Tennat PWG, Rankin J (2017) Survival, by birth weight and gestational age, in individual with congenital heart disease: a population-based study. J Am Heart Assoc 6:e005213. https://doi.org/10.1161/JAHA.116.005213
Provenchere S, Berroeta C, Reynaud C, Baron G, Poirier I, Desmonts JM, Lung B, Dehoux M, Philip I, Benessiano J, (2006) Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 34:995–1000. https://doi.org/10.1097/01.CCM.000020610.94385.C4
Yong YR, Sheu BF, Li WC, Hsieh TM, Hung CW, Chang SS, Lee CC (2014) Predictive value of plasma brain natriuretic peptide for postoperative cardiac complications: a systemic review and meta-analysis. J Crit Care 29:695e1–695e10. https://doi.org/10.1016/j.jcrc.2014.03.022
Afshani N, Schulein S, Biccard B, Thomas JM (2015) Clinical utility of B-type natriuretic peptide in pediatric cardiac surgery: a systemic review. Paediatric Anaesth 25:115–126. https://doi.org/10.1111/pan.12467
Immer FF, Stocker FP, Seiler AM, Pfammatter JP, Printzen G, Carrel TP (1988) Comparison of troponin I and troponin T after pediatric cardiovascular operation. Ann Thorac Surg 66:2073–2077. https://doi.org/10.1016/s0003-4975(98)00795-4
Lipshultz SE, Rifai N, Sallan SE, Lipstiz SR, Dalton V, Sacks DB, Ottinger ME (1997) Predictive value of troponin T in pediatric patients at risk for myocardial injury. Circulation 96:2641–2648. https://doi.org/10.1161/01.cir.96.8.2641
Mildh LH, Pettila V, Sairanen HI, Rautiainen PH (2006) Cardiac troponin T levels for risk stratification in pediatric open-heart surgery. Ann Thorac Surg 82:1643–1649. https://doi.org/10.1016/j.athoracsur.2006.05.014
Sugimoto M, Ota K, Kajihama A, Nakau K, Manabe H, Kajino H (2011) Volume overload and pressure overload due to left-to right shunt induced myocardial injury. Evaluation using a highly sensitive cardiac Troponin-I assay in children with congenital heart disease. Cir J 75:2213–2219. https://doi.org/10.1253/circj.cj-10-1211
Kayali S, Ertugruli L, Yoldas T, Kaya O, Ozgur S, Orun UA, Karademir S (2018) Sensitive cardiac troponins: could they be new biomarkers in pediatric pulmonary hypertension due to congenital heart disease? Ped Cardiol 39:718–725. https://doi.org/10.1007/s00246-018-1811-1
Dyer AK, Bares AP, Fixler DE, Shah TK, Sutclife DL, Hashim I, Drazner MH, de Lemos JA (2012) Use of a highly sensitive assay for cardiac troponin T and N-terminal pro-brain natriuretic peptide of diagnose acute rejection in pediatric cardiac transplant recipients. Am Heart J 163:595–600. https://doi.org/10.1016/j.ahj.2012.02.003
Apple FS, Wu AH, Jaffe AS (2002) European society of cardiology and American college of cardiology guideline for redefinition of myocardial infarction: how to use existing assay clinically and for clinical trial. Am Heart J 144:981–986. https://doi.org/10.1067/mhj.2002.124048
Pascual-Figal DA, Manzano-Fernandez S, Boronat M, Casa T, Garrido IP, Bonaque JC, Pastor-Perez F, Valdes M, Januzzi JL (2011) Soluble ST2, high-sensitivity troponin T-and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensate heart failure. Eur J Heart Fail 13:718–725
deFilippi CR, Seliger S (2017) A multibiomarker approach to heart failure prognostication: a work in progress. JACC Heart Fail 5:265–267. https://doi.org/10.1093/eurjhf/hfr047
Austin PC, Allignol A, Fine JP (2017) The number of primary events per variable affects estimation of the subdistribution hazard competing risk model. J Clin Epidemiol 83:75–84. https://doi.org/10.1016/j.jclinepi.2016.11.017
Miyamoto K, Takeuchi D, Inai K, Shinohara T, Nakanishi T (2016) Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricular physiology, and systemic morphologically right/left ventricle. Heart Vessels 31:1834–1847. https://doi.org/10.1007/s00380-016-0807-0
Acknowledgements
We would like to thank Editage (www.editage.com) for English language editing.
Funding
The study received no grant from any funding agency in the public, commercial, or not-profit sectors.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Data collection and analysis were performed by YM MD and YN MD. The draft of manuscript was written by YM MD. Material preparation and data collection were performed by NI MD, SK MD, and T MD. All authors read and approved the paper.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethics Approval
This cohort study was approved by the ethics committee of Seirei Hamamatsu General Hospital.
Informed consent
Parental informed consent was obtained from all patients included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mori, Y., Nakashima, Y., Kaneko, S. et al. Risk Factors for Cardiac Adverse Events in Infants and Children with Complex Heart Disease Scheduled for Bi-ventricular Repair: Prognostic Value of Pre-operative B-Type Natriuretic Peptide and High-Sensitivity Troponin T. Pediatr Cardiol 41, 1756–1765 (2020). https://doi.org/10.1007/s00246-020-02437-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-020-02437-5